NASDAQ:NRSN | Free Cash Flow | NeuroSense Therapeutics Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.67M$8,000.00-$7.68M
2024-12-31-$10.14M$3,000.00-$10.14M
2023-12-31-$8.35M$29,000.00-$8.38M
2022-12-31-$7.62M$70,000.00-$7.69M